Should I buy or sell Cronos Group stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 1 sell rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CRON shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CRON, but not buy additional shares or sell existing shares. View CRON analyst ratings or view top-rated stocks .

What is Cronos Group's stock price target for 2024?

3 Wall Street analysts have issued 12-month price objectives for Cronos Group's stock. Their CRON share price targets range from $2.50 to $3.00. On average, they predict the company's stock price to reach $2.83 in the next twelve months. This suggests a possible upside of 16.1% from the stock's current price. View analysts price targets for CRON or view top-rated stocks among Wall Street analysts .

How have CRON shares performed in 2024?

Cronos Group's stock was trading at $2.09 at the beginning of the year. Since then, CRON shares have increased by 16.7% and is now trading at $2.44. View the best growth stocks for 2024 here .

Are investors shorting Cronos Group?

Cronos Group saw a decline in short interest in March. As of March 31st, there was short interest totaling 5,550,000 shares, a decline of 13.8% from the March 15th total of 6,440,000 shares. Based on an average daily volume of 2,860,000 shares, the short-interest ratio is currently 1.9 days. Approximately 2.8% of the shares of the stock are short sold. View Cronos Group's Short Interest .

When is Cronos Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our CRON earnings forecast .

How were Cronos Group's earnings last quarter?

Cronos Group Inc. (NASDAQ:CRON) released its quarterly earnings data on Thursday, February, 29th. The company reported ($0.05) EPS for the quarter. The business had revenue of $23.92 million for the quarter, compared to analysts' expectations of $25.15 million. Cronos Group had a negative net margin of 84.15% and a negative trailing twelve-month return on equity of 3.99%.

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Tilray (TLRY) , NVIDIA (NVDA) , Advanced Micro Devices (AMD) , Dollar Tree (DLTR) , Micron Technology (MU) , Alibaba Group (BABA) and Organigram (OGI) .

Who are Cronos Group's major shareholders?

Cronos Group's stock is owned by many different institutional and retail investors. Top institutional investors include IMC Chicago LLC (0.00%). View institutional ownership trends .

How do I buy shares of Cronos Group?

Shares of CRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:CRON

Cronos Group (CRON) Stock Price, News & Analysis

→ REVEALED: Elon Musk’s Secret A.I. Facility? (From InvestorPlace) (Ad)

Free CRON Stock Alerts

$2.44

-0.07 (-2.79%)

(As of 04/15/2024 ET)

Compare

Today's Range: $2.39
▼
$2.58
50-Day Range: $1.93
▼
$2.88
52-Week Range: $1.64
▼
$2.99

Volume: 3.86 million shs
Average Volume: 4.41 million shs
Market Capitalization: $932.10 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $2.83

Get Cronos Group alerts:

Cronos Group MarketRank™ Stock Analysis

Analyst Rating: Hold
2.33 Rating Score
Upside/Downside: 16.1% Upside
$2.83 Price Target
Short Interest: Healthy
2.79% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.62
Based on 15 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.01) to $0.03 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.48 out of 5 stars

Medical Sector

739th out of 928 stocks

Medicinals & Botanicals Industry

8th out of 11 stocks

2.2

Analyst's Opinion

Consensus Rating
Cronos Group has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 2 buy ratings, no hold ratings, and 1 sell rating.
Amount of Analyst Coverage
Cronos Group has only been the subject of 1 research reports in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
2.79% of the float of Cronos Group has been sold short.
Short Interest Ratio / Days to Cover
Cronos Group has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Cronos Group has recently decreased by 13.82%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Cronos Group does not currently pay a dividend.
Dividend Growth
Cronos Group does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for CRON.

2.6

News and Social Media Coverage

News Sentiment
Cronos Group has a news sentiment score of 0.62. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 15 news articles for Cronos Group this week, compared to 2 articles on an average week.
Search Interest
15 people have searched for CRON on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.
MarketBeat Follows
Only 10 people have added Cronos Group to their MarketBeat watchlist in the last 30 days. This is a decrease of -17% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cronos Group insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 1.96% of the stock of Cronos Group is held by insiders.
Percentage Held by Institutions
Only 8.71% of the stock of Cronos Group is held by institutions.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Cronos Group are expected to grow in the coming year, from ($0.01) to $0.03 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Cronos Group is -12.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Cronos Group is -12.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Cronos Group has a P/B Ratio of 0.85. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad InvestorPlace

“Forget Tesla, this is Elon’s Next Big Thing”

According to Forbes, this breakthrough could define the future of AI. Most people don’t know about it… Because it was found 750 miles away from Silicon Valley.

Click here to see the details.

About Cronos Group Stock (NASDAQ:CRON)

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

CRON Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CRON Stock News Headlines

April 8, 2024 | marketbeat.com

Cannabis: One Stock to Play the Movement (CRON)

With talk of decriminalizing marijuana once again becoming part of the national conversation, there's one cannabis ETF that may provide the best value

April 16, 2024 | investorplace.com

3 Cannabis Penny Stocks to Buy for 3-Bagger Returns

April 16, 2024 | InvestorPlace (Ad)

REVEALED: Elon Musk’s Secret A.I. Facility?

I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.

April 13, 2024 | americanbankingnews.com

Investors Purchase High Volume of Call Options on Cronos Group (NASDAQ:CRON)

April 12, 2024 | investorplace.com

7 Penny Stocks That Could Deliver 1,000% Returns by 2029

April 10, 2024 | americanbankingnews.com

Cronos Group Target of Unusually Large Options Trading (NASDAQ:CRON)

April 9, 2024 | fool.com

Why Marijuana Stocks Got Burnt Today

April 9, 2024 | msn.com

CCH Pounder & ‘Selma’ Producer Paul Garnes To Attend First Cross Continental International Co-production Forum In Barbados

April 16, 2024 | InvestorPlace (Ad)

REVEALED: Elon Musk’s Secret A.I. Facility?

I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.

April 9, 2024 | msn.com

4 stocks to watch on Tuesday: GE, TSM and more

April 9, 2024 | americanbankingnews.com

Cronos Group (NASDAQ:CRON) Given New $2.50 Price Target at Bank of America

April 8, 2024 | msn.com

What's behind Russian frenzy to blame Ukraine for concert attack?

April 8, 2024 | fool.com

Why Canopy Growth, Cronos, and Aurora Cannabis Stocks Popped on Monday

April 8, 2024 | markets.businessinsider.com

Cautious Outlook on Cronos Group Amid Slow Regulatory Progress in Cannabis Industry

April 7, 2024 | americanbankingnews.com

Cronos Group (NASDAQ:CRON) Trading Down 3.3%

April 4, 2024 | investorplace.com

The 3 Best Meme Stocks to Buy in April 2024

April 3, 2024 | msn.com

Why Canadian Marijuana Stocks Popped Today

April 3, 2024 | fool.com

Why Canadian Marijuana Stocks Popped Today

March 29, 2024 | investorplace.com

7 High-Potential Penny Stocks to Buy for Massive ROI

March 28, 2024 | investorplace.com

The 3 Best Cannabis Stocks to Buy in Q2 2024

March 28, 2024 | investorplace.com

The 3 Best Meme Stocks to Buy in Q2 2024

March 26, 2024 | fool.com

Why Marijuana Stocks Are Hopping Again on Tuesday

March 26, 2024 | investorplace.com

3 Cannabis Stocks That Could Be Multibaggers in the Making: March Edition

March 25, 2024 | investorplace.com

Go Contrarian: 3 Analyst ‘Sells' That Could Be Buys in Disguise

March 25, 2024 | globenewswire.com

Cronos Launches Lord Jones® Chocolate Fusions

March 22, 2024 | investorplace.com

Dear Cannabis Stocks Fans, Mark Your Calendars for April 1

March 22, 2024 | fool.com

Why Tilray, Cronos, and Canopy Growth Stocks All Popped Today

See More Headlines

Receive CRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/29/2024
Today: 4/15/2024
Next Earnings (Estimated): 5/14/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Medicinals & botanicals
Sub-Industry: N/A
Current Symbol: NASDAQ:CRON
CUSIP: N/A
CIK: 1656472
Web: www.thecronosgroup.com
Phone: (416) 504-0004
Fax: N/A
Employees: 356
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $2.83
High Stock Price Target: $3.00
Low Stock Price Target: $2.50
Potential Upside/Downside: +16.1%
Consensus Rating: Hold
Rating Score (0-4): 2.33
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.19)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-73,960,000.00
Net Margins: -84.15%
Pretax Margin: -84.44%
Return on Equity: -3.99%
Return on Assets: -3.87%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 22.54
Quick Ratio: 21.81

Sales & Book Value

Annual Sales: $87.24 million
Price / Sales: 10.66
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.87 per share
Price / Book: 0.85

Miscellaneous

Outstanding Shares: 381,299,000
Free Float: 374,524,000
Market Cap: $930.37 million
Optionable: Optionable
Beta: 1.17

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

Mr. Michael Ryan Gorenstein J.D. (Age 37)
President, CEO & Chairman
Comp: $3.94M
Mr. James Holm (Age 41)
Chief Financial Officer
Comp: $314.31k
Mr. Jeffrey David Jacobson (Age 38)
Chief Growth Officer
Comp: $730.12k
Ms. Anna Shlimak (Age 38)
Senior Vice President of Corporate Affairs & Strategy
Comp: $530.5k
Mr. James Andrew McGinness III (Age 45)
VP, Controller & Principal Accounting Officer
Mr. Shayne J. Laidlaw
Director of Investor Relations & Strategy
Mr. Terry Gregory-Joseph Doucet (Age 34)
General Counsel & Corporate Secretary
Ms. Shannon Buggy (Age 54)
Senior VP & Global Head of People
Comp: $438.81k
Mr. Arye Weigensberg (Age 41)
Senior VP & Head of Research and Development

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

CRON Stock Analysis - Frequently Asked Questions

Should I buy or sell Cronos Group stock right now?: 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 1 sell rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CRON shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CRON, but not buy additional shares or sell existing shares.
View CRON analyst ratings or view top-rated stocks.
What is Cronos Group's stock price target for 2024?: 3 Wall Street analysts have issued 12-month price objectives for Cronos Group's stock. Their CRON share price targets range from $2.50 to $3.00. On average, they predict the company's stock price to reach $2.83 in the next twelve months. This suggests a possible upside of 16.1% from the stock's current price.
View analysts price targets for CRON or view top-rated stocks among Wall Street analysts.
How have CRON shares performed in 2024?: Cronos Group's stock was trading at $2.09 at the beginning of the year. Since then, CRON shares have increased by 16.7% and is now trading at $2.44.
View the best growth stocks for 2024 here.
Are investors shorting Cronos Group?: Cronos Group saw a decline in short interest in March. As of March 31st, there was short interest totaling 5,550,000 shares, a decline of 13.8% from the March 15th total of 6,440,000 shares. Based on an average daily volume of 2,860,000 shares, the short-interest ratio is currently 1.9 days. Approximately 2.8% of the shares of the stock are short sold.
View Cronos Group's Short Interest.
When is Cronos Group's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our CRON earnings forecast.

How were Cronos Group's earnings last quarter?: Cronos Group Inc. (NASDAQ:CRON) released its quarterly earnings data on Thursday, February, 29th. The company reported ($0.05) EPS for the quarter. The business had revenue of $23.92 million for the quarter, compared to analysts' expectations of $25.15 million. Cronos Group had a negative net margin of 84.15% and a negative trailing twelve-month return on equity of 3.99%.
What other stocks do shareholders of Cronos Group own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Tilray (TLRY), NVIDIA (NVDA), Advanced Micro Devices (AMD), Dollar Tree (DLTR), Micron Technology (MU), Alibaba Group (BABA) and Organigram (OGI).
Who are Cronos Group's major shareholders?: Cronos Group's stock is owned by many different institutional and retail investors. Top institutional investors include IMC Chicago LLC (0.00%).
View institutional ownership trends.
How do I buy shares of Cronos Group?: Shares of CRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CRON) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial